Buildit and Pokey, I tend to disagree. We've discussed

New Post Public Reply Private Reply Replies (2) Message Board
Zolis_onkel Buildit #15955
403
Buildit and Pokey, I tend to disagree.
We've discussed this before several times on here, the value of NGIO so far is entirely hidden so far. The spin will finally make it visible. Our why else would a company like GNBT, which owns (so far still) 100% (oh, of course, minus our dividend shares) of a sub such as NGIO, that is supposed to be worth several 100 Mill., still have a market cap of ~35 Mill.?
The spin will first of make this mostly hidden value visible to the public. So GNBT is losing nothing in value due to the spin, but will gain 70% of several 100 mill in value.
The current overall valuation of GNBT seems to be mostly based on the assumption that it is going out of business (not my opinion, just to make that clear, I still think that GNBT is highly undervalued, but all this terrible events of last year have caused a lot of frustrations and a lot of people to lose faith in GNBT and even more so in its management team), Lee all there really is missing is the finding to really jump start the different businesses (and the manufacturing facilities as it seems from those FB messages posted here earlier) and thus what these CMP and Veneto creeps have done to GNBT and in turn to us, they will never be able to compensate GNBT and us for in all there life time, no matter if GNBT wins the law suits against them or not.

Just unsung one more time, where we could be today, if the drastic drop in PPS wouldn't have happened last year (for whatever that happened) and GNBT would have continued to trade in the $3 range. We all would have received a 1:1 dividend, latest in October, the number of OS would still be in the low 60 mills, the S1s could have been filled several months earlier and at least NGIO could already be trading on Nasdaq, and all that before hopefully the big BARDA vaccine news will hit the public within the month of May,which works have a much bigger impact on the pps for both NGIO and in turn GNBT.

OK, I pinched myself, to wake up from that pipe dream ... It is just a fact that these Veneto and CMP guys can never pay us back even a fraction of the lost or currently missing value of our shares or the damage done to GNBT.
I still think that the Corona vaccine story can give GNBT and NGIO a second chance to finally win big. C'mon BARDA approve that application and pay GNBT a high 8 figure USD amount to enable them to make a vaccine available to the masses still this year.

Generex Biotechnology Corp. (GNBTQ) Stock Research Links

GNBTQ Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Historic Records Set at 2026 CNO Monumental Marathon

Updated Category News Views 530

Race to Remember: Monumental Breakthroughs In the chilly November air of Indianapolis, the 2026 CNO Financial Indianapolis Monumental Marathon wasn't just another tick on the calendar—this was a banner day for running. With record-breaking performances across every distance, we saw what happens when a community of athletes, sponsors, and volunteers hits a perfect...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 145

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading
MWC26 Doha: Bridging Standards for MENA's Future

Updated Category News Views 271

MWC26 Doha Launches with a Connectivity Mission Forget corporate boardrooms; the real action this week is unfolding in Doha's bustling exhibition halls. Kicked off with the fanfare you'd expect from such a key event, MWC26 Doha has drawn a crowd that's got both tech geeks and policy wonks nodding with interest. This ain’t your average trade show: it’s the melting pot...

Continue Reading
TCL's Display Future: AI Meets Screens at DTC 2026

Updated Category News Views 518

Exploring New Horizons in Display Technology There's something brewing in Wuhan: a conference that’s shaping up like a tech enthusiast’s dream. This year, it's all about the symbiosis of cutting-edge tech and dazzling visuals as TCL CSOT gears up to unveil advancements at the Global Display Tech-Ecosystem Conference (DTC) 2026. If you're wondering whether this event...

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 206

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 175

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
Moon Base Ambitions: Impulse Space Wins Key NASA Contracts

Updated Category News Views 630

NASA's Vision and Impulse's New Role Ever think you'd see a company like Impulse Space set to play a starring role in humanity's return to the lunar surface? Well, strap in because this isn't just a pipe dream anymore. NASA's bold plan to establish a Moon Base has taken a tangible step forward with Impulse winning two hefty task orders. This ain't just peanuts—this duo...

Continue Reading
Novo's Semaglutide Shows Promise in MASH Study

Updated Category News Views 0

Semaglutide, a name on the lips of many investors looking for breakthroughs, is making waves again. This time, the stir comes from recent findings in the MASH field, and it's got folks in white coats quite excited. Revolutionary Results from Novo Novo Nordisk has announced promising results from their phase 3 ESSENCE trial that looks into semaglutide's effects on a...

Continue Reading
Quantum Space Joins $185M NASA Lunar Transport Deal

Updated Category News Views 777

Quantum Space Bags a Chunk of NASA's Lunar Ambitions Alright, folks, buckle up because we're about to dive into the cosmos. Quantum Space just nabbed a sweet deal—a $185 million whopper of a contract from NASA's Moon Base Transportation program. This isn't chump change; it's a 25% slice for Quantum from the lot Arrow Science and Technology is heading. We're talking...

Continue Reading
Boston STEM Expo Sparks Young Minds in Engineering

Updated Category News Views 281

If you really want to light up a kid's imagination, throw them into a room full of science experiments and let 'em have at it. That's exactly what happened at the recent Society of Women Engineers' Innovation Expo in Boston's Seaport District. The place was buzzing, and not just because of all the engineering gadgets on display—it was the energy of young minds...

Continue Reading

Top 5 Most Recently Viewed Articles

Challenges Facing Halliburton Amidst Analyst Concerns

Updated Category News Views 210

Challenges for Halliburton in Today’s Market Recently, Halliburton Company (NYSE: HAL) encountered a significant challenge when a cyberattack interrupted its key business applications, leading to rising concerns among shareholders. Market Position and Diversification Analysts from RBC Capital Markets are pointing out that Halliburton's reliance on a limited range of...

Continue Reading
Wildermuth Fund Investors Urged to Act Before Deadline

Updated Category News Views 155

Crucial Action for Investors in Wildermuth Fund Investors associated with the Wildermuth Fund are facing a pivotal moment as a significant deadline looms. Financial losses sustained from the Fund's recent performance have raised alarm bells, prompting attention from legal experts. The national securities law firm, Faruqi & Faruqi, LLP, is actively investigating claims on...

Continue Reading
Innovative ShieldCRS Platform Earns Cybersecurity Recognition

Updated Category News Views 131

Alchemi's ShieldCRS Platform Achieves Prestigious Award Alchemi Data Management Inc. has recently announced the recognition of its ShieldCRS platform at the Cybersecurity Excellence Awards, which honors the best in the cybersecurity industry. The platform has set itself apart in the category of Insider Threat Protection, demonstrating its capability to provide robust...

Continue Reading
Transforming Urban Spaces: Alliance REIT's Sustainable Vision

Updated Category News Views 188

Revitalizing Urban Neighborhoods with Alliance REIT In recent years, urban developers have faced challenges with vacant properties and rising construction costs. Alliance REIT has taken a proactive approach to address these issues by rejuvenating Toronto's historic buildings and converting them into boutique multiplexes. With an innovative outlook and a commitment to...

Continue Reading
Zelluna ASA Raises NOK 58 Million to Advance Novel Therapy

Updated Category News Views 210

Zelluna ASA Secures Funding for Innovative Cancer Therapy Zelluna ASA has successfully completed a private placement and retail offering, raising NOK 58 million to move forward with ZI-MA4-1, the first "off-the-shelf" TCR-NK therapy for treating cancer. This initiative has garnered strong backing from shareholders, management, and board members, all of whom bring...

Continue Reading